Investigational drug available directly from CDC for the treatment of free-living ameba infections

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.) ; United States. Food and Drug Administration.
• Description:
  August 23, 2013, 11:30 ET (11:30 AM ET)
  
  HANINFO-00354
  
  Summary: CDC now has an expanded access investigational new drug (IND) protocol in effect with the Food and Drug Administration (FDA) to make miltefosine available directly from CDC to
  
  clinicians for treatment of free-living ameba (FLA) infections in the United States.
  
  
• Subjects:
  Acanthamoeba/drug Effects Amebiasis/drug Therapy Antiprotozoal Agents/therapeutic Use Balamuthia Mandrillaris/drug Effects Central Nervous System Protozoal Infections/drug Therapy Drugs, Investigational/therapeutic Use Encephalitis/drug Therapy Naegleria Fowleri/drug Effects Phosphorylcholine/therapeutic Use Treatment Outcome
• Source:
  HAN ; 354
• Series:
  Health Alert Network
• Document Type:
  HAN Info Service
• Place as Subject:
  United States
• Pages in Document:
  3 unnumbered pages
• Issue:
  354
• Collection(s):
  Health Alert Network (HAN)
• Main Document Checksum:
  urn:sha-512:c59920acbaa0cf6ecfdce503edc8d30f8d7103c93763dfe40852b0ce75881d3bcfb255363832acc3a425e6b945e514fc3f170328cab9ff598431f68dcbb003c4
• Download URL:
  https://stacks.cdc.gov/view/cdc/25263/cdc_25263_DS1.pdf
• File Type:
  [PDF - 1.65 MB ]